LSI's Medtech Start-Up Tracker is focused exclusively on covering the privately-held innovators changing the medical device landscape.
Quantib is developing artificial intelligence application for medical imaging analyses
The company currently commercializes two FDA-approved radiology imaging analysis platforms – Quantib ND and Quantib Brain. In June 2020, the company received a grant from the European Innovation Council $2.4M. Strategic competitors in this space include GE Healthcare, Philips, and Siemens.
Start a Free Trial to Medtech Start-Up Tracker Today
Contactless monitoring device company Circadia Health receives FDA Approval
Circadia C100 is a contactless monitoring device powered by artificial intelligence. The device remotely monitors patients for respiratory complications. Competitors offering similar solutions for the monitoring respiratory failure include SenTec and Welch Allyn.
Tatch is developing a novel patch to provide sleep clinic-quality monitoring to patients at home
Using flexible electronics and machine learning, Tatch has developed a comfortable patch capable of accurately monitoring 8 different vital variables. To-date the company has raised $4.3M million. Major competitors in this market include consumer wearable devices, such as Fitbit, as well as other companies such as Withings, Biostrap, and EarlySense.
Wireless ECG BioSense raises $500,000 in a June 2020 Seed Round
BioSense is developing a wireless ECG that can detect electrical activity in human and animal bodies through multiple layers of clothing or materials. Key strategics in the wearable ECG market include AliveCor, SonoHealth, and Omron.
CryOSA is developing novel treatments for obstructive sleep apnea
It is estimated that approximately 18 to 22 million Americans have some form of sleep apnea. The company raised $8.3M during a Series A round led by HOYA and Sante Ventures in June 2020. Other competitors developing medtech solutions for obstructive sleep apnea include Inspire and SomnoMed.
A pediatric pulmonary valve for the treatment of pediatric congenital heart disease is in development at PolyVascular
The polymeric valves will be delivered via a transcatheter approach to treat congenital heart disease, a common birth defect in infants. The transcatheter heart valve market has rapidly grown in recent years, however, Abbott is the only competitor with a valve indicated for use in infants and children.
Sonavex is using ultrasound to monitor the flow of blood
Using a bioresorbable polymeric implant and ultrasound technology, physicians can visualize and quantify anastomotic blood clots post-surgery. To-date the company has raised $11.4M. The EchoMark implant and EchoSure system received clearance from the FDA in 2019. Cook Medical and Medistim offer similar solutions for the monitoring of blood flow.
Learn about the hottest venture funded startups developing innovative medical technologies using Life Science Intelligence’s Medtech Start-Up Tracker.
Schedule an exploratory call
Request Info© 2024 Life Science Intelligence, Inc., All Rights Reserved. | Privacy Policy
